                         SEQUENCE LISTING

<110>  STAQUICINI, FERNANDA I.
       PASQUALINI, RENATA
       ARAP, WADIH
 
<120>  MUC18 TARGETING PEPTIDES

<130>  UTFC:1012WO

<140>  UNKNOWN
<141>  2009-10-15

<150>  61/105,709
<151>  2008-10-15

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  1

Cys Leu Phe Met Arg Leu Ala Trp Cys 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  2

His Asp Glu Arg Met Phe Leu Cys Lys Ser 
1               5                   10  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  3

Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys 
1               5                   10                  


<210>  4
<211>  27
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  4
ggatccttgg cttgcgccct ccgtcgg                                           27


<210>  5
<211>  30
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  5
ctaatgcctc agatcgatgt atttctctcc                                        30


<210>  6
<211>  20
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  6
cgcctggtca ccagggctgc                                                   20


<210>  7
<211>  21
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  7
caccaccctg ttgctgtagc c                                                 21


<210>  8
<211>  19
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  8
ggagagaaat acatcgatc                                                    19


<210>  9
<211>  19
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  9
gatcgatgta tttctctcc                                                    19


<210>  10
<211>  19
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  10
taaggctatg aagagatac                                                    19


<210>  11
<211>  19
<212>  DNA
<213>  Artificial

<220>
<223>  Synthetic primer

<400>  11
gtatctcttc atagcctta                                                    19


<210>  12
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  12

Arg Met Phe Leu 
1               


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Cys Phe Arg Gly Ser Thr Gly Ser Cys 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Cys Leu Tyr Leu Met Gly Gln Arg Cys 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Cys Gly Pro Val Leu Trp Gly Ala Cys 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  16

Cys Gly Ala Pro Leu Tyr Phe Ala Cys 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Cys Leu Arg Arg Ser Gly Gly Met Cys 
1               5                   


<210>  18
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Cys Phe Gln Ala Arg Val Pro Cys 
1               5               


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

Cys Leu Val Pro Gly Val Ser Ser Cys 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Cys Val Leu Asn Arg Thr Gln Leu Cys 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  21

Cys Asp Arg Gly Val Asn Gly Thr Cys 
1               5                   


<210>  22
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  22

Leu Phe Met Arg Leu Ala Trp 
1               5           


